US Patent Issued to Surface Ophthalmics on Oct. 14 for "Use of chondroitin sulfate for relieving ocular pain" (California, Minnesota Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,510, issued on Oct. 14, was assigned to Surface Ophthalmics Inc. (Pleasanton, Calif.).

"Use of chondroitin sulfate for relieving ocular pain" was invented by Richard L. Lindstrom (Wayzata, Minn.), Kamran Hosseini (Pleasanton, Calif.) and Lyle Bowman (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating ocular pain or discomfort, the method comprising: administering to an eye of a subject suffering from or at risk of suffering from ocular pain or discomfort, a therapeutically effective amount of chondroitin sulfate at a concentration of 0.1% to 2.5% wt/wt."

The patent was filed on May 3, 2024, under Application No. ...